Financhill
Buy
58

XPEV Quote, Financials, Valuation and Earnings

Last price:
$22.63
Seasonality move :
4.52%
Day range:
$23.86 - $24.77
52-week range:
$6.55 - $27.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.20x
P/B ratio:
4.93x
Volume:
18.6M
Avg. volume:
14.4M
1-year change:
154.77%
Market cap:
$22.5B
Revenue:
$4.3B
EPS (TTM):
-$0.87

XPEV Analysts' Consensus Rating

The 23 analysts providing 12-month price projections for XPeng shares anticipate an average target of $18.54, ranging from a low estimate of $7.00 to a high estimate of $35.03. This average target implies a growth of -21.87% compared to the current stock price of $23.73.

Consensus Price Target

$18.54

Highest Price Target

$35.03

Lowest Price Target

$7.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 15 15 16

Hold 7 8 7

Sell 0 0 0
Consensus Buy Buy Buy

XPEV Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock